Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Little is known about the relative importance of monocyte and tissue-resident macrophages in the development of lung fibrosis. We show that specific genetic deletion of monocyte-derived alveolar macrophages after their recruitment to the lung ameliorated lung fibrosis, whereas tissue-resident alveolar macrophages did not contribute to fibrosis. Using transcriptomic profiling of flow-sorted cells, we found that monocyte to alveolar macrophage differentiation unfolds continuously over the course of fibrosis and its resolution. During the fibrotic phase, monocyte-derived alveolar macrophages differ significantly from tissue-resident alveolar macrophages in their expression of profibrotic genes. A population of monocyte-derived alveolar macrophages persisted in the lung for one year after the resolution of fibrosis, where they became increasingly similar to tissue-resident alveolar macrophages. Human homologues of profibrotic genes expressed by mouse monocyte-derived alveolar macrophages during fibrosis were up-regulated in human alveolar macrophages from fibrotic compared with normal lungs. Our findings suggest that selectively targeting alveolar macrophage differentiation within the lung may ameliorate fibrosis without the adverse consequences associated with global monocyte or tissue-resident alveolar macrophage depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
From Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool 61.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Mo-AMs, but not TR-AMs, are responsible for the pro-fibrotic activity of this group of cells1,3,10,13”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Macrophage polarization refers to distinct sets of inflammatory (M1) or fibrotic (M2) genes that are expressed by macrophages in cell culture that are first induced toward differentiation and then treated with LPS and IFN-γ or IL-4, respectively (Martinez and Gordon, 2014; Murray et al., 2014).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398 · cited 3×
“…using FastQC, reads were trimmed and aligned to mm10 reference genome using TopHat2, read counts were associated with genes using the GenomicRanges (Lawrence et al., 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor…”
MethodInfluentialGOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“2387 IntroductIon Van Furth and colleagues suggested an adult monocytic origin of all macrophages, but it is now clear that many tissue-resident macrophages, including alveolar macrophages in the lung, are self-renewing populations that arise from fetal progenitors and require minimal input from circuiting adult monoc…”
BackgroundSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 3×
“Extending the findings from several groups (Guilliams et al., 2013; Hashimoto et al., 2013; van de Laar et al., 2016), we found that TR-AMs were remarkably stable, constituting >95% of alveolar macrophages at 14 mo of age (Fig.”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“This “macrophage polarization” model is based on limited evidence and is conceptually incomplete (Xue et al., 2014; Nahrendorf and Swirski, 2016).”
Background
Cited by
Items 301–400 of 998
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis
Burgy, O., Loriod, S., Beltramo, G., & Bonniaud, P. (2022) · Cells · doi:10.3390/cells11071209 · Cited by 51
Tissue-resident immunity in the lung: a first-line defense at the environmental interface
Zazara, D. E., Belios, I., Lücke, J., Zhang, T., & Giannou, A. D. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00964-2 · Cited by 48
Niethamer, T. K., Planer, J. D., Morley, M. P., Babu, A., Zhao, G., Basil, M. C., Cantu, E., Frank, D. B., Diamond, J. M., Nottingham, A. N., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2024.12.002 · Cited by 53
Origin and production of inflammatory perivascular macrophages in pulmonary hypertension
Florentin, J., & Dutta, P. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.015 · Cited by 46
“observed a novel population of alveolar macrophages, which are derived from blood monocytes in the context of pulmonary fibrosis [51].”
BackgroundTsitoura, E., Trachalaki, A., Vasarmidi, E., Mastrodemou, S., Margaritopoulos, G. A., Kokosi, M. A., Fanidis, D., Galaris, A., Aidinis, V., Renzoni, E. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645548 · Cited by 46
“Macrophages, the most abundant immune cells in the lung, play important roles in tissue remodelling during pulmonary fibrosis (14).”
BackgroundRecruitment and training of alveolar macrophages after pneumococcal pneumonia
Arafa, E. I., Shenoy, A. T., Barker, K. A., Etesami, N. S., Martin, I. M. C., Ana, C. L. D., Na, E., Odom, C. V., Goltry, W. N., Korkmaz, F. T., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.150239 · Cited by 47
“Prior studies comparing AM of adult HSC origin versus embryonic origin suggested they were largely similar (18, 19).”
InfluentialYou, Y., Yuan, H., Min, H., Li, C. R., & Chen, J. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132489 · Cited by 50
Regulation of macrophage activation by lactylation in lung disease
Wei, Y., Guo, H., Chen, S., & Tang, X. X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427739 · Cited by 53
The role of macrophage-derived TGF-β1 on SiO 2 -induced pulmonary fibrosis: A review
Zhang, Z., Tian, H.-T., Hu, L., & Xie, R. (2021) · Toxicology and Industrial Health · doi:10.1177/0748233721989896 · Cited by 51
“Studies have recently shown that monocyte-derived alveolar macrophages, rather than alveolar-resident macrophages, are causally related to fibrosis severity (McQuattie-Pimentel et al., 2018; Misharin et al., 2017).”
BackgroundAlveolar macrophages drive lung fibroblast function in cocultures of IPF and normal patient samples
Novak, C. M., Sethuraman, S., Luikart, K. L., Reader, B. F., Wheat, J. S., Whitson, B. A., Ghadiali, S. N., & Ballinger, M. N. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00263.2022 · Cited by 44
Pisu, D., Johnston, L., Mattila, J. T., & Russell, D. G. (2024) · Nature Communications · doi:10.1038/s41467-024-52846-w · Cited by 48
The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer
Wang, Q., Steger, A., Mahner, S., Jeschke, U., & Heidegger, H. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133310 · Cited by 45
“Tissue-resident macrophage maintenance and homeostasis depend on its origin in the steady state, which can be disturbed by pathological or physiological inflammation [8,14].”
BackgroundIncreased flux through the mevalonate pathway mediates fibrotic repair without injury
Larson‐Casey, J. L., Vaid, M., Gu, L., He, C., Cai, G.-Q., Ding, Q., Davis, D., Berryhill, T. F., Wilson, L. S., Barnes, S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127959 · Cited by 46
Macrophage PPAR-γ suppresses long-term lung fibrotic sequelae following acute influenza infection
Huang, S., Goplen, N. P., Zhu, B., Cheon, I. S., Son, Y. M., Wang, Z., Li, C., Dai, Q., Jiang, L., Xiang, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223430 · Cited by 43
“Indeed, emerging evidence has suggested that a dichotomous stratification of macrophage phenotypes (M1 versus M2) oversimplifies the functional heterogeneity of these highly plastic cells [5, 53, 54].”
BackgroundHong, S., Lu, Y., Chen, S.-Y., Hsu, C.-F., Lu, Y.-C., Wang, C., & Huang, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05876-z · Cited by 42
Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization
Deng, L., Ouyang, B., Shi, H., Yang, F., Li, S., Xie, C. H., Du, W., Hu, L., Wei, Y., & Dong, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116810 · Cited by 44
Targeting helminths: The expanding world of type 2 immune effector mechanisms
Maizels, R. M., & Gause, W. C. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20221381 · Cited by 45
Wohnhaas, C. T., Bassler, K. E., Watson, C. K., Shen, Y., Leparc, G., Tilp, C., Heinemann, F., Kind, D., Stierstorfer, B., Delić, D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1325090 · Cited by 47
Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotype
Tiotiu, A. I., Kermani, N. Z., Badi, Y. E., Pavlidis, S. P., Hansbro, P. M., Guo, Y., Chung, K. F., & Adcock, I. M. (2020) · Allergy · doi:10.1111/all.14535 · Cited by 44
Becerra-Díaz, M., Lerner, A. D., Yu, D. H., Thiboutot, J. P., Liu, M. C., Yarmus, L. B., Bose, S., & Heller, N. M. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104252 · Cited by 43
McErlean, P. K., Bell, C. G., Hewitt, R. J., Busharat, Z., Ogger, P. P., Ghai, P., Albers, G. J., Calamita, E., Kingston, S., Molyneaux, P. L., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202101-0004oc · Cited by 48
“Ontogeny of AMs is complex encompassing both self-renewing-fetal-derived ‘resident’ and monocyte-derived ‘recruited’ cells(2).”
BackgroundA novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung
Matsuhira, T., Nishiyama, O., Tabata, Y., Kaji, C., Kubota-Ishida, N., Chiba, Y., Sano, H., Iwanaga, T., & Tohda, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173508 · Cited by 41
Airway Macrophages Encompass Transcriptionally and Functionally Distinct Subsets Altered by Smoking
Liegeois, M. A., Bai, Q., Fiévez, L., Pirottin, D., Legrand, C., Guiot, J., Schleich, F., Corhay, J.-L., Louis, R. E., Marichal, T., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0563oc · Cited by 44
McKendrick, J. G., Jones, G., Elder, S. S., Watson, E. E., T’Jonck, W., Mercer, E., Pinto, M. M., Rocchi, C., Hegarty, L. M., Johnson, A. L., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add4374 · Cited by 47
“Importantly, macrophages of differing origins have been shown to play functionally-distinct roles in the context of infection and fibrosis in the lung (14, 15), in cardiac regeneration after myocardial infarction (16), and in the CNS in response to systemic endotoxin (17).”
The aging lung: microenvironment, mechanisms, and diseases
Wang, Y., Huang, X., Luo, G., Xu, Y., Deng, X., Lin, Y., Wang, Z., Zhou, S., Wang, S., Chen, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1383503 · Cited by 66
Bordag, N., Biasin, V., Schnoegl, D., Valzano, F., Jandl, K., Nagy, B. M., Sharma, N., Wygrecka, M., Kwapiszewska, G., & Marsh, L. M. (2020) · iScience · doi:10.1016/j.isci.2020.101819 · Cited by 47
“However, multiple inflammatory cells have been implicated in disease pathogenesis, including macrophages (Misharin et al., 2017; Reyfman et al., 2019) and T cells (Todd et al., 2013), which are connected with poorer prognosis (Balestro et al., 2016).”
BackgroundResultInfluentialAirway macrophage-intrinsic TGF-β1 regulates pulmonary immunity during early-life allergen exposure
Branchett, W. J., Cook, J., Oliver, R. A., Bruno, N., Walker, S. A., Stölting, H., Mack, M., O’Garra, A., Saglani, S., & Lloyd, C. M. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.01.026 · Cited by 45
Aging and respiratory viral infection: from acute morbidity to chronic sequelae
Wu, Y., Goplen, N. P., & Sun, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00624-2 · Cited by 46
“To this end, certain macrophage populations including those monocytederived alveolar macrophages were shown to promote lung fibrosis following bleomycin and influenza-induced lung injury models [85].”
BackgroundNtatsoulis, K., Karampitsakos, Τ., Tsitoura, E., Stylianaki, E.-A., Matralis, A. N., Tzouvelekis, A., Antoniou, K. M., & Aidinis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687397 · Cited by 45
“scRNAseq analysis of BALF cells from COVID-19 patients indicated a predominance of macrophages (100, 101), where ENPP2 mRNA expression was detected in monocyte-derived alveolar macrophages (Mo-AMs) (61), that have been shown to drive the development of BLMinduced pulmonary fibrosis in mice (105).”
Planer, J. D., & Morrisey, E. E. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031621-024344 · Cited by 43
“Moreover, following inflammation, recruited cells of the monocyte-macrophage lineage persist in tissue and eventually adopt a transcriptional profile that is similar to native alveolar macrophages (24), suggesting that signals within the alveolar niche dictate the behavior of myeloid cells.”
BackgroundLack of evidence for increased transcriptional noise in aged tissues
Ibañez-Solé, O., Ascensión, A. M., Araúzo-Bravo, M. J., & Izeta, A. (2022) · eLife · doi:10.7554/elife.80380 · Cited by 40
Geng, F., Zhao, L., Cai, Y., Zhao, Y. R., Jin, F., Li, Y., Li, T., Yang, X., Li, S., Gao, X., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040202 · Cited by 43
Hyaluronan interactions with innate immunity in lung biology
Tighe, R. M., & Garantziotis, S. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.027 · Cited by 41
“During inflammation, macrophages derived from monocytes are recruited from the circulation and can exhibit diverse functions in support of inflammation [51, 52] and the development of fibrosis [53].”
BackgroundSirtuin 2 enhances allergic asthmatic inflammation
Lee, Y. G., Reader, B. F., Herman, D. D., Streicher, A., Englert, J. A., Ziegler, M., Chung, S., Karpurapu, M., Park, G. Y., Christman, J. W., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124710 · Cited by 44
“Exciting new work has emerged that has begun to identify derivation markers to distinguish between embryonic and bone marrow derived macrophage subpopulations in the lung (38, 39); however, additional work is needed to fully understand”
BackgroundRunyan, C. E., Welch, L. C., Lecuona, E., Shigemura, M., Amarelle, L., Abdala‐Valencia, H., Joshi, N., Lu, Z., Nam, K.-W., Markov, N. S., et al. (2020) · Aging Cell · doi:10.1111/acel.13180 · Cited by 41
Self-citationBeyond “Big Eaters”: The Versatile Role of Alveolar Macrophages in Health and Disease
Hetzel, M., Ackermann, M., & Lachmann, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073308 · Cited by 41
Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis
Roach, K., Castells, E., Dixon, K., Mason, S., Elliott, G., Marshall, H., Poblocka, M., Macip, S., Richardson, M., Khalfaoui, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.679388 · Cited by 39
Penke, L. R. K., Speth, J. M., Huang, S. K., Fortier, S. M., Baas, J. D., & Peters-Golden, M. L. (2022) · JCI Insight · doi:10.1172/jci.insight.160688 · Cited by 44
“Lung macrophages are also implicated in pulmonary fibrogenesis (35, 36), and in particular M2-polarized macrophages are prime producers of the profibrotic cytokine TGF-β (37, 38).”
Association of immune cell recruitment and BPD development
Heydarian, M., Schulz, C., Stoeger, T., & Hilgendorff, A. (2022) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-022-00148-w · Cited by 47
Roles of Macrophages and Endothelial Cells and Their Crosstalk in Acute Lung Injury
Valencia, S. O., & Zhou, B. (2024) · Biomedicines · doi:10.3390/biomedicines12030632 · Cited by 52
Euthanasia- and Lavage-mediated Effects on Bronchoalveolar Measures of Lung Injury and Inflammation
Tighe, R. M., Birukova, A., Yaeger, M. J., Reece, S. W., & Gowdy, K. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0357oc · Cited by 39
Lee, J., Kim, H., Kang, K., Jeong, H., Song, M.-K., Tae, I. H., Lee, S., Kim, H., Lee, K., Chae, S., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02657-x · Cited by 36
P2 Purinergic Signaling in the Distal Lung in Health and Disease
Wirsching, E., Fauler, M., Fois, G., & Frick, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144973 · Cited by 44
Wagner, J. G., Barkauskas, C. E., Vose, A. T., Lewandowski, R. P., Harkema, J. R., & Tighe, R. M. (2020) · Environmental Health Perspectives · doi:10.1289/ehp7255 · Cited by 39
“…single cell and transcriptomic analytical approaches con fi rm a central role of airspace and interstitial macrophages in the pathogenesis of human fi brotic lung disease and rodent experimental pulmonary fi brosis models (Aran et al. 2019; Misharin et al. 2017b; Reyfman et al. 2019; Yu et al. 2016).”
Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
Kletukhina, S. K., Mutallapova, G., Андреевна, Т. А., & Gomzikova, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911212 · Cited by 40
“Classic monocytes have been shown to infiltrate into the fibrotic lung in the early stages of fibrosis and subsequently mature to profibrotic inflammatory alveolar macrophages [156].”
BackgroundLi, X., Liu, Y., Tang, Y., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474688 · Cited by 65
Exosomes: Carriers of Pro-Fibrotic Signals and Therapeutic Targets in Fibrosis
Li, M., Jiang, M., Meng, J., & Tao, L. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191209161443 · Cited by 38
Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities
Yao, M., Liu, Z., Zhao, W., Song, S., Huang, X., & Wang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1567994 · Cited by 61
Targeting defective pulmonary innate immunity – A new therapeutic option?
Belchamber, K. B. R., & Donnelly, L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107500 · Cited by 41
MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity
Vega, M. A., Simón‐Fuentes, M., de la Aleja, A. G., Nieto, C., Colmenares, M., Herrero, C., Domínguez‐Soto, Á., & Corbí, A. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603507 · Cited by 41
“Importantly, self-maintenance and persistence of the SPP1 subset is dependent on M-CSF/MCSFR signaling (35), what correlates with their specific expression of MAFB (33, 34), the high number of MAFB+ CD68+ macrophages detected in pulmonary fibrosis patients (33, 34) and their expression of MAFB-dependent pro-fibrotic g…”
BackgroundChronic lung diseases: prospects for regeneration and repair
Barnes, P. J., Anderson, G. P., Fagerås, M., & Belvisi, M. G. (2021) · European Respiratory Review · doi:10.1183/16000617.0213-2020 · Cited by 39
Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis
Wu, X., Zhang, D., Qiao, X., Zhang, L., Cai, X., Ji, J., Ma, J. A., Zhao, Y., Belperio, J. A., Boström, K. I., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.01799-2022 · Cited by 43
Heterogeneity in lung macrophage control of Mycobacterium tuberculosis is modulated by T cells
Lai, R., Williams, T., Rakib, T., Lee, J., & Behar, S. M. (2024) · Nature Communications · doi:10.1038/s41467-024-48515-7 · Cited by 40
“The SiglecF int CD11c + (MDM1) were the most variable between experiments and could be immature AM 22 – 24 .”
BackgroundAtif, S. M., Gibbings, S. L., Redente, E. F., Camp, F. A., Torres, R. M., Kedl, R. M., Henson, P. M., & Jakubzick, C. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0159oc · Cited by 41
Pietro, C. D., Öz, H. H., Murray, T. S., & Bruscia, E. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01059 · Cited by 37
“…it is not surprising that many chronic lung inflammatory diseases such asthma, chronic obstructive pulmonary disease (COPD), CF (Bruscia and Bonfield, 2016a; Bruscia and Bonfield, 2016b), and pulmonary fibrosis (Misharin et al., 2017; Reyfman et al., 2019), are associated with abnormal MF behavior.”
BackgroundMitochondria complex III–generated superoxide is essential for IL-10 secretion in macrophages
Stoolman, J. S., Grant, R. A., Billingham, L. K., Poor, T. A., Weinberg, S. E., Harding, M. C., Lu, Z., Miska, J. M., Szibor, M., Budinger, G. R. S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu4369 · Cited by 36
“Lung and blood single-cell suspensions were prepared as previously described ( 60 ).”
Self-citationHou, F., Shi, N., Yuan, H., LI, B. C., Xiao, J., Xiao, K., & Xie, L. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00750-6 · Cited by 46
“Lung injury is often accompanied by the development of pulmonary fibrosis, and the persistent presence of abnormal MDMs is a major contributor to the onset of fibrosis [141].”
Oncostatin M in the Regulation of Connective Tissue Cells and Macrophages in Pulmonary Disease
Richards, C. D., & Botelho, F. M. (2019) · Biomedicines · doi:10.3390/biomedicines7040095 · Cited by 35
Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 41
Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis
Jeny, F., Bernaudin, J., Valeyre, D., Kambouchner, M., Pretolani, M., Nunès, H., Planès, C., & Besnard, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719009 · Cited by 38
“Notably, upon injury, the myeloid precursors generate monocyte-derived (MD) macrophages, though to play a major role in fibrosis (16) and sarcoidosis (11, 17–20).”
BackgroundAlveolar macrophages: novel therapeutic targets for respiratory diseases
Lim, P. N., Cervantes, M. M., Pham, L. K., & Rothchild, A. C. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.21 · Cited by 39
“(2) Passive targeting modifies physiochemical characteristics such as size”
BackgroundNuclear envelope disruption triggers hallmarks of aging in lung alveolar macrophages
De Silva, N. S., Siewiera, J., Alkhoury, C., Nader, G. P. F., Nadalin, F., de Azevedo, K., Couty, M., Izquierdo, H. M., Bhargava, A., Conrad, C., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00488-w · Cited by 34
Choi, S. M., Mo, Y., Bang, J., Ko, Y. G., Ahn, Y. H., Kim, H. Y., Koh, J., Yim, J., & Kang, H. (2023) · Respiratory Research · doi:10.1186/s12931-023-02357-x · Cited by 36
“Another study reported the expansion of lung macrophages derived from monocytes in explanted lungs of recipients with pulmonary fibrosis [50].”
BackgroundResultInfluentialLi, S., Xu, H., Liu, S., Hou, J., Han, Y., Li, C., Li, Y., Zheng, G., Wei, Z., Fang, Y., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01288-5 · Cited by 44
Serpa, G. L., Renton, N., Lee, N., Crane, M. J., & Jamieson, A. M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0200oc · Cited by 39
Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development
Kamata, T., So, T. Y., Ahmed, Q., Giblett, S. M., PATEL, B., Luo, J., Reddel, R. R., & Pritchard, C. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107802 · Cited by 35
Warheit-Niemi, H. I., Edwards, S. J., SenGupta, S., Parent, C. A., Zhou, X., O’Dwyer, D. N., & Moore, B. B. (2022) · JCI Insight · doi:10.1172/jci.insight.152690 · Cited by 44
“Like other researchers (19, 20), we observed significant differences in the composition of the total macrophage population of the fibrotic lung, with increases in TR-AMs, Mo-AMs, IMs, and inflammatory macrophages at baseline (Figure 8A).”
IRE1α drives lung epithelial progenitor dysfunction to establish a niche for pulmonary fibrosis
Auyeung, V. C., Downey, M. S., Kathiriya, J. J., Thamsen, M., Wenger, T. A., Backes, B. J., Brumwell, A. N., Chapman, H. A., Sheppard, D., & Papa, F. R. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00408.2021 · Cited by 37
Xiao, H., Peng, L., Jiang, D., Liu, Y., Zhu, L., Li, Z., Geng, J., Xie, B., Huang, X., Wang, J., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17600 · Cited by 37
He, S., Tian, R., Zhang, X., Yao, Q., Chen, Q., Liu, B., Liao, L., Gong, Y., Yang, H., & Wang, D. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109293 · Cited by 38
NADPH Oxidase Inhibition in Fibrotic Pathologies
Bernard, K. F., & Thannickal, V. J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8032 · Cited by 34
“Pulmonary fibrosis has also been associated with the recruitment of macrophages and neutrophils at site of tissue remodeling (78, 89, 94, 172).”
BackgroundZhang, Y., Wang, S., He, X., Guo, J., He, K., Huang, C., Luo, R., Chen, Y., Xu, K., Gao, H., et al. (2021) · Engineering · doi:10.1016/j.eng.2021.05.009 · Cited by 38
“Moreover, monocytes are one of the main cell types that induce pulmonary fibrosis [4,5].”
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities
Kim, J. S., Axelsson, G. T., Moll, M. R., Anderson, M. R., Bernstein, E. J., Putman, R. K., Hida, T., Hatabu, H., Hoffman, E. A., Raghu, G., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1967oc · Cited by 34
The role of monocyte-derived macrophages in the lung: It’s all about context
T’Jonck, W., & Bain, C. C. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106421 · Cited by 38
Wang, L., Li, Z., Wan, R., Pan, X., Li, B., Zhao, H., Yang, J., Zhao, W., Wang, S., Wang, Q., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0080oc · Cited by 42
“Previous fi ndings have shown that the epithelial barrier in IPF is compromised (23) and that monocytes and macrophages are heavily in fi ltrated (24).”
BackgroundDipali, S. S., King, C. D., Rose, J., Burdette, J. E., Campisi, J., Schilling, B., & Duncan, F. E. (2023) · Aging · doi:10.18632/aging.205190 · Cited by 53
“Monocytes that migrate to fibrotic lungs transform into macrophages and remain in the lungs with high profibrotic gene expression [62].”
BackgroundMechanisms of inflammation modulation by different immune cells in hypertensive nephropathy
Hao, X., Liu, Y., Hailaiti, D., Gong, Y., Zhang, X.-D., Yue, B., Liu, J., Wu, X., Yang, K., Wang, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1333170 · Cited by 47
Impact of Cigarette Smoke Exposure on the Lung Fibroblastic Response after Influenza Pneumonia
Lee, S. W., Sharma, L., Kang, Y. A., Kim, S., Chandrasekharan, S., Losier, A., Brady, V., Bermejo, S. D., Andrews, N., Yoon, C.-M., et al. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0004oc · Cited by 33
“Furthermore, it has been shown that monocyte-derived alveolar macrophages are able to drive lung fibrosis and persist in the lung over the life span (39).”
BackgroundOverexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice
Wang, Y., Kuai, Q., Gao, F., Wang, Y., He, M., Zhou, H., Han, G., Jiang, X., Ren, S., & Yu, Q. T. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0070oc · Cited by 35
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Smith, J. N. P., Witkin, M. D., Jogasuria, A. P., Christo, K. F., Raffay, T. M., Markowitz, S. D., & Desai, A. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68336-0 · Cited by 33
Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4–associated Tissue Repair Macrophages
Watson, C. K., Schloesser, D., Fundel‐Clemens, K., Lerner, C., Gabler, S., Baskaran, P., Wohnhaas, C. T., Dichtl, S., Huber, H. J., Ask, K., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0021oc · Cited by 38
The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Jiang, A., Liu, N., Wang, J., Zheng, X., Ren, M., Zhang, W., & Yao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022228 · Cited by 34
Innate Immune Training Initiates Efferocytosis to Protect against Lung Injury
Kang, Y.-Y., Kim, D.-Y., Lee, S.-Y., Kim, H.-J., Kim, T.-H., Cho, J.-A., Lee, T., & Choi, E. Y. (2024) · Advancement of science · doi:10.1002/advs.202308978 · Cited by 31
Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options
Hewitt, R. J., & Maher, T. M. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00647-y · Cited by 34
CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases
Greiffo, F. R., Viteri-Alvarez, V., Frankenberger, M., Dietel, D., Ortega‐Gómez, A., Lee, J. S., Hilgendorff, A., Behr, J., Soehnlein, O., Eickelberg, O., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00460-2019 · Cited by 33
Gangwar, R. S., Vinayachandran, V., Palanivel, R., Chan, R., Park, B., Diamond‐Zaluski, R., Cara, E. A., Cha, A., Das, L. M., Asase, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71144-1 · Cited by 35
Fibroblasts and their responses to chronic injury in pulmonary fibrosis
Wu, B., Tang, L. F., & Kapoor, M. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.12.003 · Cited by 37
Hu, A., Hong, F., Li, D., Jin, Y., Kon, L., Xu, Z., He, H., & Xie, Q. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02682-5 · Cited by 31
“LncRNA ROR inhibition has been reported to trigger autophagy in breast cancer to overturn resistance to Tamoxifen [11].”
BackgroundAdvances in single-cell sequencing: insights from organ transplantation
Wang, Y., Wang, J., Schnieke, A., & Fischer, K. (2021) · Military Medical Research · doi:10.1186/s40779-021-00336-1 · Cited by 38
GM-CSF: Orchestrating the Pulmonary Response to Infection
McCormick, T. S., Hejal, R. B., Leal, L. O., & Ghannoum, M. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735443 · Cited by 35
“proliferation of resident AM is generally sufficient (Misharin et al., 2017; Guilliams et al., 2020).”
BackgroundHult, E. M., Gurczynski, S. J., O’Dwyer, D. N., Zemans, R. L., Rasky, A. J., Wang, Y., Murray, S., Crawford, H. C., & Moore, B. B. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0174oc · Cited by 34
Wu, X., Wu, L., Wu, Y., Chen, W., Chen, J., Gong, L., & Yu, J. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.11.032 · Cited by 33
Strunz, M., Simon, L. M., Ansari, M., Mattner, L. F., Angelidis, I., Mayr, C. H., Kathiriya, J. J., Yee, M., Ogar, P., Sengupta, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/705244 · Cited by 31
New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis
Wang, Z. N., & Tang, X. X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580026 · Cited by 34
“At present, there are only two FDA-approved drugs for patients with Abbreviations: α6, integrin α6; AEC1, type I alveolar epithelial cells; AEC2, type II alveolar epithelial cells; β4, integrin β4; BADJ, bronchioalveolar-duct junction; BASCs, bronchioalveolar stem cells; BMP, bone morphogenetic protein; CC10, club cel…”
BackgroundInfluentialChu, S., McCormick, T. S., Lazarus, H. M., Leal, L. O., & Ghannoum, M. A. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108731 · Cited by 32
Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
Isshiki, T., Vierhout, M., Naiel, S., Ali, P., Yazdanshenas, P., Kumaran, V. R., Yang, Z., Dvorkin‐Gheva, A., Rullo, A. F., Kolb, M. R. J., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115501 · Cited by 33
Pulmonary macrophages and SARS-Cov2 infection
Bain, C. C., Lucas, C. D., & Rossi, A. G. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.01.001 · Cited by 34
Macrophage Cx43 Is Necessary for Fibroblast Cytosolic Calcium and Lung Fibrosis After Injury
Bhattacharyya, A., Torre, P., Yadav, P., Boostanpour, K., Chen, T. Y., Tsukui, T., Sheppard, D., Muramatsu, R., Seed, R., Nishimura, S. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880887 · Cited by 30
Cellular senescence is a key mediator of lung aging and susceptibility to infection
Torrance, B. L., & Haynes, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006710 · Cited by 32
“With age, these cells begin to be replenished by bone marrow-derived monocytes rather than by self-renewal (104).”
BackgroundPerrot, C. Y., Karampitsakos, Τ., Unterman, A., Adams, T. S., Marlin, K., Arsenault, A., Zhao, A., Kaminski, N., Katlaps, G. J., Patel, K., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00563.2023 · Cited by 31
Metadata
- Authors
- Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., Abdala-Valencia, H., Yacoub, T. J., Chi, M., Chiu, S., Gonzalez-Gonzalez, F. J., Gates, K., Lam, A. P., Nicholson, T. T., Homan, P. J., Soberanes, S., Dominguez, S., Morgan, V. K., Saber, R., Shaffer, A., Hinchcliff, M., Marshall, S. A., Bharat, A., Berdnikovs, S., Bhorade, S. M., Bartom, E. T., Morimoto, R. I., Balch, W. E., Sznajder, J. I., Chandel, N. S., Mutlu, G. M., Jain, M., Gottardi, C. J., Singer, B. D., Ridge, K. M., Bagheri, N., Shilatifard, A., Budinger, G. R. S., & Perlman, H.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 1
- Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 2
- Scripps Research Institute (US)
- University of Chicago (US)
- Corresponding author
- Perlman, Harris
- ORCID
- Misharin, Alexander V.
- Reyfman, Paul A.
- Cuda, Carla M.
- Walter, James M.
- McQuattie-Pimentel, Alexandra C.
- Chen, Ching-I
- Anekalla, Kishore R.
- Joshi, Nikita
- Chiu, Stephen
- Gonzalez-Gonzalez, Francisco J.
- Lam, Anna P.
- Nicholson, Trevor T.
- Homan, Philip J.
- Soberanes, Saul
- Dominguez, Salina
- Morgan, Vince K.
- Saber, Rana
- Shaffer, Alexander
- Hinchcliff, Monique
- Marshall, Stacy A.
- Bharat, Ankit
- Berdnikovs, Sergejs
- Bhorade, Sangeeta M.
- Bartom, Elizabeth T.
- Morimoto, Richard I.
- Balch, William E.
- Sznajder, Jacob I.
- Chandel, Navdeep S.
- Mutlu, Gökhan M.
- Jain, Manu
- Gottardi, Cara J.
- Singer, Benjamin D.
- Ridge, Karen M.
- Bagheri, Neda
- Shilatifard, Ali
- Budinger, G.R. Scott
- Perlman, Harris
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-10
- Volume
- 214
- Issue
- 8
- Pages
- 2387-2404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5551573
- OpenAlex
- W2736034593
- Cited by
- 1,133
- References
- 87
- Citations by year
- 2026: 139 · 2025: 131 · 2024: 156 · 2023: 135 · 2022: 136 · 2021: 128 · 2020: 134 · 2019: 81 · 2018: 77 · 2017: 15
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (AR064313, HL128867, T32 DK077662, HL125940, AG049665, HL048129, HL071643, HL085534, ES015024, ES025644, HL079190, HL124664, ES013995, AR064546, HL134375)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061593)
- Scleroderma Foundation
- Department of Defense (PR141319)
- BD Bioscience
- Northwestern University (5T32 HL076139-13)
- American Society for Transplant Surgery Foundation
- Thoracic Surgery Foundation
- Society of University Surgeons
- American Association of Thoracic Surgery
- Parker B. Francis
- Veterans Administration (BX000201)
- Mabel Greene Myers
- National Cancer Institute (P30 CA060553)
- Feinberg School of Medicine
- American Thoracic Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- pulmonary fibrosis, alveolar macrophages, monocyte-derived macrophages, tissue-resident macrophages, monocyte-to-macrophage differentiation, fibrosis resolution, gene deletion, gene expression profiling
- MeSH terms
- Animals, Cell Differentiation, Fibrosis, Humans, Lung, Monocytes, Macrophages, Alveolar, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.